Boston Millennia Partners provides private equity financing to high growth companies in the healthcare and life sciences industry. Our team brings over one hundred years of combined private equity experience to the investment process. Our broad experience, combined with expertise in finance; operations; engineering; life sciences research and development; partnering with pharmaceutical companies; business development; executive recruiting; and law provides significant value to the companies in which we invest. Since the early 1980’s, members of our team have managed seven venture capital partnerships with very successful results for our investors and our entrepreneurs. The growth and success of our portfolio companies have, in turn, allowed us to grow and expand our capital base to over $700 million under management.
Dana Callow Talks with Bloomberg's Pimm Fox
Dana Callow talks with Bloomberg's Pimm Fox about the outlook for venture capital firms. Dana also discusses returns in the industry and Boston Millennia's investments in the health-care.
The VC Expert's Buzz Interview with Dana Callow,
In depth interview discussing the state of the VC industry, exciting investment sectors, status of the IPO market, current lending environment, advice to entrepreneurs, and investing in healthcare/life sciences industry.
Cultivating Second Chances
Have an achy knee? Maybe you need to grow some new cartilage for it. Article From American Way Magazine regarding BMP's portfolio company Histogenics.
CombinatoRx Reports Positive Phase 2 Trial Results for CRx-401
CombinatoRx reported positive results for its Phase 2 clinical study of CRx-401 as an add-on to metformin therapy in Type 2 diabetes which demonstrated that CRx-401 performed statistically significantly better than bezafibrate on the primary efficacy endpoint.
Click Here to receive news updates 
